March 28, 2016
Rhodes Pharmaceuticals LP on Friday challenged Allergan PLC's request for approval of a generic version of attention deficit hyperactivity disorder medication Aptensio XR, contending in a New Jersey federal court suit that the pharmaceutical giant is violating a number of the company's patents.